Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease

American Journal of Gastroenterology

Volumn 107, Issue 12, 2012, Pages 1862-1871

  Wong, Vincent Wai Sun ^a,b   Vergniol, Julien ^c   Wong, Grace Lai Hung ^a,b   Foucher, Juliette ^c   Chan, Anthony Wing Hung ^b   Chermak, Faiza ^c   Choi, Paul Cheung Lung ^b   Merrouche, Wassil ^c   Chu, Shirley Ho Ting ^a,b   Pesque, Sophie ^c   Chan, Henry Lik Yuen ^a,b   De Lédinghen, Victor ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CAUCASIAN; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING EQUIPMENT; DIAGNOSTIC TEST ACCURACY STUDY; ELASTOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER HISTOLOGY; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INVASIVE PROCEDURE; NONALCOHOLIC FATTY LIVER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STEATOSIS; WAIST CIRCUMFERENCE;

ADULT; AGED; AREA UNDER CURVE; BIOPSY; BODY MASS INDEX; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; FRANCE; HONG KONG; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84870819164     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.331     Document Type: Article

References (32)

1. Williams CD, Stengel J, Asike MI et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140: 124-31.
2. Wong VW, Chu WC, Wong GL et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012; 61: 409-15.
3. Wong VW, Wong GL, Choi PC et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010; 59: 969-74.
4. Ascha MS, Hanouneh IA, Lopez R et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010; 51: 1972-8.
5. Bhala N, Angulo P, van der Poorten D et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology 2011; 54: 1208-16.
6. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363: 1341-50.
7. Wong VW, Wong GL, Tsang SW et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut 2011; 60: 829-36.
8. Wong VW, Wong GL, Yip GW et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 2011; 60: 1721-7.
9. Fraquelli M, Rigamonti C, Casazza G et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56: 968-73.
10. Wong GL, Wong VW, Choi PC et al. Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. Clin Gastroenterol Hepatol 2008; 6: 1027-35.
11. Wong VW, Chan HL. Transient elastography. J Gastroenterol Hepatol 2010; 25: 1726-31.
12. Castera L, Foucher J, Bernard PH et al. Pitfalls of liver stiff ness measurement: a 5-year prospective study of 13, 369 examinations. Hepatology 2010; 51: 828-35.
13. Wong GL, Wong VW, Chim AM et al. Factors associated with unreliable liver stiff ness measurement and its failure with transient elasto graphy in the Chinese population. J Gastroenterol Hepatol 2011; 26: 300-5.
14. Wong VW, Hui AY, Tsang SW et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006; 4: 1154-61.
15. de Ledinghen V, Vergniol J, Foucher J et al. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int 2010; 30: 1043-8.
16. Myers RP, Pomier-Layrargues G, Kirsch R et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiff ness measurement in overweight and obese patients. Hepatology 2012; 55: 199-208.
17. de Ledinghen V, Wong VW, Vergniol J et al. Diagnosis of liver fibrosis and cirrhosis using liver stiff ness measurement: comparison between M and XL probe of FibroScan(R). J Hepatol 2012; 56: 833-9.
18. Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-5.
19. Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-21.
20. Chan HL, Wong GL, Choi PC et al. Alanine aminotransferase-based algorithms of liver stiff ness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009; 16: 36-44.
21. Nahon P, Kettaneh A, Tengher-Barna I et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J Hepatol 2008; 49: 1062-8.
22. Nobili V, Vizzutti F, Arena U et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 2008; 48: 442-8.
23. Gaia S, Carenzi S, Barilli AL et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol 2011; 54: 64-71.
24. Petta S, Di Marco V, Camma C et al. Reliability of liver stiff ness measurement in non-alcoholic fatty liver disease: the eff ects of body mass index. Aliment Pharmacol Ther 2011; 33: 1350-60.
25. Wong VW, Vergniol J, Wong GL et al. Diagnosis of fibrosis and cirrhosis using liver stiff ness measurement in nonalcoholic fatty liver disease. Hepatology 2010; 51: 454-62.
26. Friedrich-Rust M, Hadji-Hosseini H, Kriener S et al. Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur Radiol 2010; 20: 2390-6.
27. Myers RP. Noninvasive diagnosis of nonalcoholic fatty liver disease. Ann Hepatol 2009; 8 (Suppl 1): S25-33.
28. Shah AG, Lydecker A, Murray K et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009; 7: 1104-12.
29. Das K, Sarkar R, Ahmed SM et al. " Normal " liver stiff ness measure (LSM) values are higher in both lean and obese individuals: A population-based study from a developing country. Hepatology 2012; 55: 584-93.
30. Myers RP, Pomier-Layrargues G, Kirsch R et al. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol 2012; 56: 564-70.
31. Lucidarme D, Foucher J, Le Bail B et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49: 1083-9.
32. Roulot D, Costes JL, Buyck JF et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 2011; 60: 977-84.